OakChart

Schrodinger Inc

SDGRHealthcare·Health Information Services·USA·Mid·NASD·Nov 11 • 3:09 PM ET

31.61-0.80 (-2.47%)
2026-11-11 21:09 CET
Market cap
2,433.27 USD m
Revenue, TTM
269.20 USD m
Net income, TTM
-59.25 USD m
Free cash flow, TTM
-116.77 USD m
EPS diluted, TTM
-0.79
P/E
-
Compare

Price

SDGR against its 20, 50 and 200-day averages
2050200beat
15.0020.0025.0030.0035.004.5M9.0MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SDGRclose 31.6120-day 27.1050-day 26.55200-day 17.2931.6152w high52w low

7.0% under the 52-week high of 34.00 on 11 Nov 2026. 52-week low 10.95 on 27 Mar 2026. Last 15 sessions, 54.5% high to low

Volume 0.82× normal · the line is the 50-bar volume average

Profile

SDGR
52-week range, 90% of the way up
10.9433.78

Schrodinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.

IndexRUT
Employees850
IPOFeb 06, 2020
Beta1.62
ATR, 14d2.35
Rel volume0.82
Short float15.34%
Insider own15.34%
Inst own87.14%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap2.37B
Enterprise Value2.10B
Income-59.25M
Sales269.20M
Book/sh4.02
Cash/sh4.97
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees850
IPOFeb 06, 2020

Ratios

P/E-
Forward P/E-
PEG-
P/S8.82
P/B7.86
P/C6.36
P/FCF-
EV/EBITDA-
EV/Sales7.82
Quick Ratio2.75
Current Ratio2.75
Debt/Eq0.35
LT Debt/Eq0.30
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.79
EPS next Y-1.42
EPS next Q-0.26
EPS this Y-4.47%
EPS next Y3.51%
EPS next 5Y11.76%
EPS past 3/5Y12.46% -28.10%
Sales past 3/5Y12.24% 18.81%
EPS Y/Y TTM66.98%
Sales Y/Y TTM4.77%
EPS Q/Q-13.06%
Sales Q/Q18.72%
EarningsNov 04 AMC
EPS/Sales Surpr.24.98% 35.11%

Ownership

Insider Own15.34%
Insider Trans-0.56%
Inst Own87.14%
Inst Trans-0.66%
ROA-9.36%
ROE-19.02%
ROIC-15.14%
Gross Margin58.52%
Oper. Margin-49.64%
Profit Margin-22.01%
SMA2016.64%
SMA5019.07%
SMA20082.82%
Trades-

Technical

Shs Outstand65.86M
Shs Float63.56M
Short Float15.34%
Short Ratio4.82
Short Interest9.75M
52W High33.78 -6.42%
52W Low10.94 188.81%
Volatility9.87% 8.48%
ATR (14)2.35
RSI (14)60.71
Beta1.62
Rel Volume0.82
Avg Volume2.02M
Volume1,445,520

Performance

Perf Week10.83%
Perf Month22.09%
Perf Quarter71.24%
Perf Half Y147.92%
Perf YTD76.79%
Perf Year72.73%
Perf 3Y15.66%
Perf 5Y-30.00%
Perf 10Y-
Recom1.57
Target Price33.57
Prev Close32.41
Price31.61
Change %-2.47%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Aug 14, 2026ResumedUUBSNeutral$19-39.9%
Dec 15, 2025UpgradeBBofA SecuritiesNeutral → Buy$24-24.1%
Sep 30, 2025InitiatedGGoldmanNeutral$19-39.9%
Aug 15, 2025DowngradeCCitigroupBuy → Neutral$20-36.7%
Aug 14, 2025InitiatedBBarclaysOverweight$25-20.9%
Jul 03, 2025ResumedMMorgan StanleyEqual-Weight$28-11.4%
Jul 02, 2024InitiatedLLeerink PartnersOutperform$29-8.3%
Dec 05, 2023InitiatedKKeyBanc Capital MarketsOverweight$38+20.2%
May 05, 2023ResumedPPiper SandlerOverweight$60+89.8%
Dec 19, 2022InitiatedGGoldmanNeutral$23-27.2%

Peers

Mkt cap
TickerCompanyMkt cap
CERTCertara Inc1.79B
RXRXRecursion Pharmaceuticals Inc2.21B
RLAYRelay Therapeutics Inc4.38B
ABSIAbsci Corp1.68B
TEMTempus AI Inc14.55B
VEEVVeeva Systems Inc49.76B
ABCLAbCellera Biologics Inc3.97B
DNAGinkgo Bioworks Holdings Inc720.55M
IQVIQVIA Holdings Inc45.67B
ICLRIcon Plc15.04B

Insider trading

latest 14 of 43
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Tran YvonneEVP, CLO & CPONov 09 '26Option Exercise17.0032,000544,00084,683Nov 10 04:16 PM
Tran YvonneEVP, CLO & CPONov 09 '26Sale32.8532,0001,051,12352,683Nov 10 04:16 PM
YVONNE TRANOfficerNov 09 '26Proposed Sale29.8232,000954,240Nov 09 04:35 PM
Akinsanya KarenSee RemarksSep 17 '26Option Exercise4.3431,599137,140101,555Sep 21 05:15 PM
Akinsanya KarenSee RemarksSep 17 '26Sale29.3731,599927,97069,956Sep 21 05:15 PM
KAREN OLUFUNMILYO AKINSANYA-AKOfficerSep 17 '26Proposed Sale23.9331,599756,164Sep 17 04:27 PM
Jain RachitEVP & CFOJul 16 '26Sale15.6087513,64750,877Jul 17 05:09 PM
Jain RachitOfficerJul 16 '26Proposed Sale15.6087513,647Jul 16 03:19 PM
Aklian Mannix VartanOfficerJul 01 '26Proposed Sale16.681,13618,949Jul 01 03:19 PM
Herman JennyOfficerMay 01 '26Proposed Sale12.261,95724,000May 01 03:18 PM
Farid RamyPresident & CEOApr 17 '26Option Exercise3.07117,527360,808405,351Apr 17 06:09 PM
Farid RamyPresident & CEOApr 16 '26Option Exercise3.0743,000132,010373,824Apr 17 06:09 PM
Farid RamyPresident & CEOApr 16 '26Sale12.3343,000530,233330,824Apr 17 06:09 PM
Farid RamyPresident & CEOApr 17 '26Sale12.2143,000524,944330,824Apr 17 06:09 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
ARKGARK Genomic Revolution ETFAUM: 1.97B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
IJTiShares S&P Small-Cap 600 Growth ETFAUM: 7.45B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-04-0.500-0.667-0.50064.4947.737
2026Q22026-08-050.080-0.4150.07958.8947.197
2026Q12026-05-05-0.810-0.623-0.81158.5947.578
2025Q42026-02-250.450-0.1840.44187.2083.768
2025Q32025-11-05-0.450-0.717-0.44654.3249.7110
2025Q22025-08-06-0.590-0.768-0.58854.7652.059
2025Q12025-05-07-0.820-0.726-0.81959.6054.668
2024Q42025-02-26-0.550-0.424-0.55288.3083.208
2024Q32024-11-12-0.520-0.633-0.52435.2941.257
2024Q22024-07-31-0.740-0.832-0.74347.3339.6110
2024Q12024-05-01-0.760-0.742-0.75736.6041.969
2023Q42024-02-28-0.320-0.400-0.42574.1079.1210
2023Q32023-11-01-0.860-0.687-0.86242.6037.858
2023Q22023-08-020.060-0.5080.05735.1938.277
2023Q12023-05-041.7501.2851.74964.7864.956
2022Q42023-02-28-0.390-0.501-0.38256.8047.448

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-0.550--0.38885.53-
2020FY-0.410-0.387-0.408108.1112.44
2021FY-1.420-1.316-1.422137.93128.74
2022FY-2.100-2.076-2.096180.96172.13
2023FY0.5400.5950.543216.67221.28
2024FY-2.570-2.433-2.575207.54202.24
2025FY-1.410-1.960-1.410255.87252.21
2026FY--1.473--254.15
2027FY--1.421--245.27
2028FY--0.969--277.8
2029FY--0.010--371.8
2030FY-0.400--406.5

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-1061570.6652.8087.16
2026Q4S2026-11-0561472.4552.8087.16
2026Q4S2026-11-0460176.5853.7088.00
2026Q4S2026-10-2760176.5853.7088.00
2026Q4S2026-10-2061176.5853.7088.00
2026Q4S2026-10-1962376.5853.7088.00
2026Q4S2026-10-0962376.5853.7088.00
2026Q4S2026-09-2363277.3053.7090.36
2026Q4S2026-08-1363377.3053.7090.36
2026Q4S2026-08-0662376.2753.7090.36
2026Q4S2026-07-2060175.5156.8088.20
2026Q4S2026-07-1061575.5156.8088.20
2026Q4S2026-07-0261575.6856.8088.20
2026Q4S2026-05-0671675.1756.8088.20

Estimate history

EPS, annual-0.275-0.449-0.388-0.408-1.422-2.0960.543-2.575-1.406-0.7949
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.524-0.552-0.819-0.588-0.4460.441-0.8110.079-0.504
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual55.69366.63985.543108.095137.931180.955216.666207.539255.869269.2
Period201720182019202020212022202320242025TTM
Sales, quarterly35.2988.31759.55154.75954.32487.23558.58758.88964.491
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual63.26563.26563.26569.87870.99971.32872.14272.87573.6875.029
Period201720182019202020212022202320242025MRQ
Shares, quarterly72.84672.87573.34373.58573.63473.6874.54874.77975.029
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue269.20255.87207.54216.67180.96137.93108.0985.5466.64
Cost of Goods Sold Incl. D&A111.68113.2575.4676.5680.4574.3047.2239.1823.74
Gross Profit157.53142.61132.08140.10100.5163.6360.8746.3642.90
Selling, General and Administrative Excl. Other291.15309.51341.38317.55247.33175.07121.7985.0870.87
Research and Development160.31173.14201.78181.77126.3790.0963.8838.7934.52
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-133.63-166.90-209.30-177.45-146.82-111.44-60.92-38.72-27.97
Interest Expense0.000.00--0.000.000.00-0.00
Unusual Expense-64.63-48.17-5.68-53.4618.08-11.36-28.26-9.920.81
Net Income Before Taxes-56.85-102.33-185.7142.92-149.13-100.81-26.29-25.97-28.35
Income Taxes2.400.941.412.200.060.410.34-0.290.08
Consolidated Net Income-59.25-103.27-187.1240.72-149.19-101.22-26.64-25.68-28.43
Net Income From Continuing Operations-59.25-103.27-187.1240.72-149.19-100.39-24.46-24.57-28.43
Net Income-59.25-103.27-187.1240.72-149.19-100.39-24.46-24.57-28.43
EPS (Recurring)-1.40-1.87-2.630.04-1.92-1.53-0.74-0.50-0.44
EPS (Basic, Before Extraordinaries)-0.79-1.41-2.580.57-2.10-1.42-0.41-0.39-0.45
EPS (Diluted)-0.79-1.41-2.580.54-2.10-1.42-0.41-0.39-0.45
EBITDA-127.77-160.87-203.14-171.90-142.47-108.60-57.26-35.08-25.07
Non-Operating Income (Expense)12.1516.4017.90166.9115.78-0.726.362.820.43
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense28.2433.9739.4237.7931.3119.347.701.600.96
Price To Earnings Ratio---63.64-----
Price To Sales Ratio8.645.136.7512.397.3517.8343.97--
Gross Margin58.5255.7463.6464.6655.5446.1356.3154.2064.38
Operating Margin-49.64-65.23-100.85-81.90-81.13-80.80-56.35-45.26-41.97
Net Margin-22.01-40.36-90.1618.79-82.44-72.78-22.63-28.72-42.66
Shares Outstanding75.0373.6872.8772.1471.3371.0069.8863.2763.27
Market Capitalization2,433.272,433.271,404.242,578.771,331.432,463.825,501.995,686.82-

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue64.4958.8958.5987.2354.3254.7659.5588.32
Cost of Goods Sold Incl. D&A26.2426.4629.0429.9426.2928.6028.4325.51
Gross Profit38.2532.4329.5557.2928.0426.1631.1262.81
Selling, General and Administrative Excl. Other64.3873.9878.3474.4573.9979.0682.0183.52
Research and Development34.0941.0043.8241.4042.7643.1445.8448.47
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-26.13-41.55-48.79-17.16-45.95-52.90-50.89-20.71
Interest Expense0.000.000.000.000.000.00--
Unusual Expense14.75-45.8713.49-47.00-9.69-4.5813.1022.08
Net Income Before Taxes-37.557.35-59.6232.97-32.63-42.89-59.78-39.25
Income Taxes0.161.370.410.460.160.290.030.96
Consolidated Net Income-37.715.97-60.0332.51-32.80-43.17-59.81-40.22
Net Income From Continuing Operations-37.715.97-60.0332.51-32.80-43.17-59.81-40.22
Net Income-37.715.97-60.0332.51-32.80-43.17-59.81-40.22
EPS (Recurring)-0.37-0.34-0.68-0.01-0.54-0.63-0.69-0.34
EPS (Basic, Before Extraordinaries)-0.500.08-0.810.44-0.45-0.59-0.82-0.55
EPS (Diluted)-0.500.08-0.810.44-0.45-0.59-0.82-0.55
EBITDA-24.67-40.06-47.32-15.72-44.48-51.37-49.30-19.08
Non-Operating Income (Expense)3.333.032.663.133.625.444.203.54
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense6.266.957.177.868.578.409.149.86
Price To Sales Ratio8.644.753.305.155.756.216.266.77
Gross Margin59.3255.0750.4365.6851.6147.7752.2671.12
Operating Margin-40.52-70.55-83.28-19.67-84.58-96.61-85.45-23.45
Net Margin-58.4710.15-102.4637.27-60.37-78.84-100.43-45.54
Shares Outstanding75.0374.7874.5573.6873.6373.5973.3472.87
Market Capitalization2,433.271,214.21838.651,317.121,476.541,476.341,441.781,404.24

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments402.33367.45468.75456.33579.48643.1986.3384.0736.34
Short Term Receivables104.39255.3389.1269.0940.5535.3825.7418.029.76
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets12.5412.219.938.575.034.416.472.601.95
Total Current Assets519.26634.99567.80533.99625.06682.98118.54104.6948.05
Net Property, Plant & Equipment122.19136.08141.10120.2385.4115.2719.037.975.44
Total Investments and Advances73.6543.2183.2525.6843.1745.6615.375.442.61
Intangible Assets4.794.794.795.38--0.000.010.05
Other Assets6.264.166.013.312.852.352.342.611.87
Total Assets726.16823.23802.96688.59756.49746.26155.27120.7358.02
Short Term Debt Incl. Current Port. of LT Debt16.4116.7516.8711.012.044.545.580.000.00
Accounts Payable11.4510.6716.829.478.088.403.522.771.61
Other Current Liabilities161.27164.3399.9988.3281.0960.2635.9124.2316.21
Total Current Liabilities189.14191.75133.67108.8091.2173.2045.0227.0017.82
Long Term Debt92.82101.07111.01105.4877.837.228.890.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities80.16108.969.7126.4030.3641.823.103.603.26
Total Liabilities362.11401.78254.40240.68199.40122.2457.0130.6021.07
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00191.58161.6982.31
Common Equity364.05421.44548.56447.89557.07624.01-93.36-71.56-45.36
Total Shareholders Equity364.05421.44548.56447.89557.07624.0198.2290.1336.95
Accumulated Minority Interest0.000.000.000.010.010.000.040.000.00
Total Equity364.05421.44548.56447.90557.09624.0298.2690.1336.95
Total Liabilities & Stockholders Equity726.16823.23802.96688.59756.49746.26155.27120.7358.02
Book Value Per Share4.945.787.606.287.858.93-1.48-1.13-0.72
Tangible Book Value Per Share4.885.727.546.207.858.93-1.48-1.13-0.72
Full-Time Employees850891867787664452394--
Price to Book Ratio8.063.134.572.874.448.879.01--
Return on Assets-13.33-23.015.46-20.65-13.36-5.43-17.81-31.80-
Return on Equity-26.29-38.588.17-29.69-17.00-6.77-26.09-44.74-
Return on Invested Capital-22.60-35.816.17-26.96-15.81-3.88-22.94-31.54-47.07
Quick Ratio2.753.314.254.916.859.332.633.882.70
Current Ratio2.753.314.254.916.859.332.633.882.70

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-59.25-103.27-187.1240.72-149.19-101.22-26.64-25.68-28.43
Depreciation5.866.026.165.554.342.853.663.642.86
Other Funds (Non Cash)-29.17-7.0236.64-13.2458.3623.40-19.44-8.311.58
Funds from Operations-82.56-104.27-144.3333.03-86.48-74.97-42.42-30.35-23.99
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-30.01118.17-13.04-22.55-21.384.6859.184.290.28
Cash from Operating Activities-112.5813.90-157.3710.48-107.86-70.2916.76-26.06-23.71
Capital Expenditures-4.20-1.44-7.31-13.40-8.01-7.17-2.54-1.84-5.26
Net Assets From Acquisitions0.000.000.000.00-6.430.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.030.000.100.00
Purchase or Sale of Investments184.7759.34156.1559.2292.64-10.02-379.18-52.0216.45
Purchase of Investments-244.18-312.96-254.41-324.75-272.07-418.50-522.54-110.19-3.65
Sale Or Maturity of Investments428.94372.30410.56383.97364.71408.48143.3558.1720.10
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities180.5757.90148.8445.8278.20-17.16-381.72-53.7611.19
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock4.192.9910.189.072.117.93541.2730.4480.27
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock4.192.9910.189.072.117.93541.2730.4480.27
Proceedsfrom Stock Options0.000.008.69-0.370.000.00537.0930.4480.27
Issuance or Reduction of Debt, Net-0.05-0.06-0.06-0.020.000.000.000.000.00
Change in Long Term Debt-0.05-0.06-0.06-0.020.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt-0.05-0.06-0.06-0.020.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.00-1.860.00
Other Financing Activities Uses0.000.000.000.000.000.000.00-1.860.00
Cash from Financing Activities4.142.9310.129.052.117.93541.2728.5880.27
Net Change in Cash72.1374.731.5965.35-27.55-79.53176.31-51.2367.76
Free Cash Flow-116.7712.46-164.68-2.92-115.87-77.4614.22-27.89-28.97
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00--
Price to Free Cash Flow-105.42----334.25--
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments373.38418.80406.42402.33400.99462.26
Short Term Receivables70.8341.1248.18104.3957.4036.78
Inventories0.000.000.000.000.000.00
Other Current Assets12.3310.559.3512.5413.3414.95
Total Current Assets456.54470.48463.96519.26471.72514.00
Net Property, Plant & Equipment116.60120.37120.64122.19125.84129.06
Total Investments and Advances27.0939.0539.8373.6544.3834.69
Intangible Assets4.794.794.794.794.794.79
Other Assets6.915.714.976.266.925.71
Total Assets611.94640.39634.19726.16653.66688.24
Short Term Debt Incl. Current Port. of LT Debt15.1916.4816.0116.4116.7416.84
Accounts Payable7.9510.3211.9511.459.228.80
Other Current Liabilities143.16147.04141.58161.27119.16130.13
Total Current Liabilities166.29173.84169.54189.14145.11155.77
Long Term Debt89.4491.5090.9492.8294.6997.47
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities54.3846.0960.1580.1692.5092.13
Total Liabilities310.11311.44320.64362.11332.31345.37
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity301.83328.96313.55364.05321.35342.87
Total Shareholders Equity301.83328.96313.55364.05321.35342.87
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity301.83328.96313.55364.05321.35342.87
Total Liabilities & Stockholders Equity611.94640.39634.19726.16653.66688.24
Book Value Per Share4.024.404.214.944.364.66
Tangible Book Value Per Share3.964.334.144.884.304.59
Full-Time Employees---850--
Price to Book Ratio8.063.862.304.104.313.95
Return on Assets-9.36-8.18-15.03-13.33-26.61-26.34
Return on Equity-19.02-16.18-30.12-26.29-45.67-44.40
Return on Invested Capital-9.641.42-14.847.12-7.88-9.80
Quick Ratio2.752.712.742.753.253.30
Current Ratio2.752.712.742.753.253.30

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-37.715.97-60.0332.51-32.80-43.17
Depreciation1.461.491.481.441.471.53
Other Funds (Non Cash)22.12-36.6321.91-36.570.485.25
Funds from Operations-14.13-29.17-36.64-2.62-30.85-36.39
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-33.45-4.9021.81-13.47-31.03-15.81
Cash from Operating Activities-47.58-34.07-14.83-16.09-61.87-52.20
Capital Expenditures-1.29-0.36-2.51-0.04-0.49-0.31
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments7.2358.9847.1171.4511.95-55.29
Purchase of Investments-70.93-69.94-34.05-69.25-77.64-138.51
Sale Or Maturity of Investments78.17128.9281.16140.7089.5983.22
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities5.9458.6244.6071.4111.46-55.60
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock2.730.670.580.210.322.03
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock2.730.670.580.210.322.03
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-0.01-0.01-0.01-0.01-0.01-0.01
Change in Long Term Debt-0.01-0.01-0.01-0.01-0.01-0.01
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-0.01-0.01-0.01-0.01-0.01-0.01
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities2.720.650.570.200.312.02
Net Change in Cash-38.9125.2030.3355.51-50.11-105.78
Free Cash Flow-48.87-34.43-17.34-16.13-62.36-52.51
Price to Free Cash Flow---105.76-60.62

Revenue breakdown

Drug Discovery2024: 27.17M 2025: 56.37M
Software Products And Services2024: 180.37M 2025: 199.50M
APAC2024: 25.80M 2025: 26.18M
EMEA2024: 65.65M 2025: 75.16M
Non-US2024: 1.22M 2025: 1.56M
United States2024: 114.87M 2025: 152.96M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3015.34%9.8M63.6M1.99M
2026-10-1516.43%10.4M63.3M1.84M
2026-09-3016.01%10.1M63.3M1.49M
2026-09-1517.65%11.2M63.3M1.21M
2026-08-3117.52%11.1M63.3M1.22M
2026-08-1418.05%11.4M63.3M1.28M
2026-07-3117.42%11.0M63.2M1.30M
2026-07-1516.74%10.6M63.2M1.45M
2026-06-3016.61%10.5M63.3M1.46M
2026-06-1515.80%10.0M63.4M1.34M
2026-05-2916.46%10.4M63.3M1.32M
2026-05-1516.27%10.3M63.1M1.36M
2026-04-3016.68%10.4M62.2M1.44M
2026-04-1517.51%10.9M62.3M1.41M
2026-03-3117.68%11.1M62.9M1.36M
2026-03-1318.01%11.3M62.9M1.33M
2026-02-2717.61%11.1M62.9M1.24M
2026-02-1317.08%10.7M62.7M1.14M
2026-01-3017.37%10.9M62.7M1.02M
2026-01-1516.86%10.6M62.7M987.57K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.5028.6031.4010.7525.6210.000.000.997-0.0190.000
call5.0026.5028.9027.0014.38184.000.000.995-0.0200.001
call7.5023.7026.4011.8010.72064.000.000.987-0.0480.002
call10.0021.1023.9020.078.59367.000.000.983-0.0480.002
call12.5018.8021.4017.207.1053860.000.980-0.0470.002
call15.0016.5018.9018.045.9351890.000.975-0.0460.003
call17.5014.0016.4012.604.9832990.000.969-0.0450.003
call20.0011.5013.9013.204.1691,1141.000.962-0.0430.004
call22.509.0011.4010.073.4491640.000.952-0.0410.005
call25.006.309.007.702.86066612.000.905-0.0610.008
call27.504.305.705.141.74558780.000.830-0.0750.012
call30.002.403.302.901.2401,62711.000.672-0.0950.018
call32.501.151.501.460.9461,2691040.458-0.1040.020
call35.000.500.700.600.92910,6833590.269-0.0860.016
call37.500.050.450.371.0496204.000.174-0.0750.013
call40.000.050.300.301.1631,29318.000.115-0.0630.010
call42.500.052.200.301.36981.000.000.102-0.0680.009
call45.000.001.000.121.5321680.000.093-0.0710.008
put2.500.000.050.007.2260.000.00-0.003-0.0170.000
put5.000.000.050.475.2001.000.00-0.004-0.0180.001
put7.500.000.250.054.78620.000.00-0.009-0.0340.001
put10.000.000.250.043.8912,6130.00-0.012-0.0340.002
put12.500.000.250.103.2083360.00-0.014-0.0340.002
put15.000.001.200.062.5691750.00-0.019-0.0330.002
put17.500.000.500.472.0974450.00-0.023-0.0320.003
put20.000.000.250.041.6853370.00-0.028-0.0300.003
put22.500.000.150.121.3165860.00-0.036-0.0290.004
put25.000.050.300.071.2521477.00-0.095-0.0590.008
put27.500.000.500.201.0355184.00-0.170-0.0720.012
put30.000.300.900.430.8452453.00-0.324-0.0930.018
put32.501.802.251.600.90640.0013.00-0.542-0.1010.020
put35.002.504.103.800.97571.000.00-0.731-0.0820.016
put37.503.906.400.001.2150.000.00-0.826-0.0710.013
put40.006.208.6022.701.1300.000.00-0.885-0.0590.010
put42.508.7011.100.001.4080.000.00-0.898-0.0630.009
put45.0011.2013.900.001.9310.000.00-0.907-0.0670.008

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-104Statement of changes in beneficial ownership of securities2026-11-09SEC
2026-11-09144Filing for proposed sale of securities under Rule 144.SEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-09-214Statement of changes in beneficial ownership of securities2026-09-17SEC
2026-09-17144Filing for proposed sale of securities under Rule 144.SEC
2026-08-05S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-058-KCurrent report2026-08-05SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-16SEC
2026-07-16144Filing for proposed sale of securities under Rule 144.SEC
2026-07-01144Filing for proposed sale of securities under Rule 144.SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-06-298-KCurrent report2026-06-29SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-22SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-22SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-22SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-22SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-22SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-22SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-22SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-22SEC
2026-06-238-KCurrent report2026-06-22SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-22SEC
2026-06-088-KCurrent report2026-06-05SEC
2026-05-208-KCurrent report2026-05-18SEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-058-KCurrent report2026-05-05SEC
2026-05-01144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-11001.05M1
2026-100000
2026-0900927.97K1
2026-080000
2026-070013.65K1
2026-060000
2026-050000
2026-04001.07M3
2026-0300150.19K8
2026-020050.40K4
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.14.08%
GATES FOUNDATION TRUST9.34%
Rubric Capital Management LP8.57%
VANGUARD PORTFOLIO MANAGEMENT LLC5.07%
Amova Asset Management Americas, Inc.3.62%
VANGUARD CAPITAL MANAGEMENT LLC3.60%
Sumitomo Mitsui Trust Group, Inc.3.41%
STATE STREET CORP3.08%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC2.97%
ARK Investment Management LLC2.88%

Funds

Fund% owned
iShares Core S&P Small-Cap ETF4.60%
ARK Genomic Revolution ETF2.73%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.63%
iShares Russell 2000 ETF1.99%
VANGUARD SMALL-CAP INDEX FUND1.91%
MFS New Discovery Fund1.21%
VANGUARD SMALL-CAP GROWTH INDEX FUND1.12%
VANGUARD EXTENDED MARKET INDEX FUND0.89%
Fidelity Small Cap Index Fund0.85%
iShares Russell 2000 Growth ETF0.73%

OakChart. SDGR. Cached 15 minutes.